NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications

The use of posttransplant cyclophosphamide (PT-Cy) as graft-versus-host disease (GVHD) prophylaxis has revolutionized haploidentical hematopoietic stem cell transplantation (HSCT), allowing safe infusion of unmanipulated T cell–replete grafts. PT-Cy selectively eliminates proliferating alloreactive...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood
Auteurs principaux: Russo, Antonio, Oliveira, Giacomo, Berglund, Sofia, Greco, Raffaella, Gambacorta, Valentina, Cieri, Nicoletta, Toffalori, Cristina, Zito, Laura, Lorentino, Francesca, Piemontese, Simona, Morelli, Mara, Giglio, Fabio, Assanelli, Andrea, Stanghellini, Maria Teresa Lupo, Bonini, Chiara, Peccatori, Jacopo, Ciceri, Fabio, Luznik, Leo, Vago, Luca
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2018
Sujets:
Transplantation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5757695/
https://ncbi.nlm.nih.gov/pubmed/28986344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-05-780668
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires